Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society

Hiroyuki Kuwano; Yasumasa Nishimura; Tsuneo Oyama; Hiroyuki Kato; Yuko Kitagawa; Motoyasu Kusano; Hideo Shimada; Hiroya Takiuchi; Yasushi Toh; Yuichiro Doki; Yoshio Naomoto; Hisahiro Matsubara; Tatsuya Miyazaki; Manabu Muto; Akio Yanagisawa

doi:10.1007/s10388-014-0465-1

Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society

Hiroyuki Kuwano, Yasumasa Nishimura, Tsuneo Oyama, Hiroyuki Kato, Yuko Kitagawa, Motoyasu Kusano, Hideo Shimada, Hiroya Takiuchi, Yasushi Toh, Yuichiro Doki, Yoshio Naomoto, Hisahiro Matsubara, Tatsuya Miyazaki, Manabu Muto, Akio Yanagisawa

常任理事

研究成果: Article › 査読

352 被引用数 (Scopus)

本文言語	English
ページ（範囲）	1-30
ページ数	30
ジャーナル	Esophagus
巻	12
号	1
DOI	https://doi.org/10.1007/s10388-014-0465-1
出版ステータス	Published - 2015 1月 1

ASJC Scopus subject areas

消化器病学

文献へのアクセス

10.1007/s10388-014-0465-1

他のファイルとリンク

引用スタイル

Kuwano, H., Nishimura, Y., Oyama, T., Kato, H., Kitagawa, Y., Kusano, M., Shimada, H., Takiuchi, H., Toh, Y., Doki, Y., Naomoto, Y., Matsubara, H., Miyazaki, T., Muto, M., & Yanagisawa, A. (2015). Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society. Esophagus, 12(1), 1-30. https://doi.org/10.1007/s10388-014-0465-1

Kuwano, H, Nishimura, Y, Oyama, T, Kato, H, Kitagawa, Y, Kusano, M, Shimada, H, Takiuchi, H, Toh, Y, Doki, Y, Naomoto, Y, Matsubara, H, Miyazaki, T, Muto, M & Yanagisawa, A 2015, 'Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society', Esophagus, vol. 12, no. 1, pp. 1-30. https://doi.org/10.1007/s10388-014-0465-1

@article{cb4a5460ed1047e788d67c6592a034c3,

title = "Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society",

keywords = "Clinical guidelines, Esophagus, Neoplasm",

author = "Hiroyuki Kuwano and Yasumasa Nishimura and Tsuneo Oyama and Hiroyuki Kato and Yuko Kitagawa and Motoyasu Kusano and Hideo Shimada and Hiroya Takiuchi and Yasushi Toh and Yuichiro Doki and Yoshio Naomoto and Hisahiro Matsubara and Tatsuya Miyazaki and Manabu Muto and Akio Yanagisawa",

note = "Funding Information: Funds to support the development of these guidelines were provided by the Japan Esophageal Society and the Ministry of Health, Labour and Welfare Scientific Research (Study on the appropriate development and publication of guidelines for the diagnosis and treatment while maintaining full disclosure: Hirata{\textquoteright}s study group). Prof. Kitagawa has received grants from Taiho Pharmaceutical CO., LTD., Chugai Pharmaceutical CO., LTD., Kyowa Hakko Kirin CO., LTD., Merck Serono CO., LTD., Ono Pharmaceutical CO., LTD., Novartis Pharma CO., LTD., Yakult Honsha CO., LTD., Bristol-Myers Squibb Daiichi Sankyo CO., LTD., Shionogi CO., LTD., Terumo Corporation, Torii Pharmaceutical Co., Ltd., AstraZeneca CO., LTD. Other authors have no conflict of interest to declare with profit making or nonprofit organizations or providers of medical products and medical supplies. The Ethics Committee and Administrative Board of the Japan Esophageal Society required members of the Committee to Develop Guidelines for the Treatment of Carcinoma of the Esophagus and the Guideline Evaluation Committee to self-report any potential conflict of interest. ",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/s10388-014-0465-1",

language = "English",

volume = "12",

pages = "1--30",

journal = "Esophagus",

issn = "1612-9059",

publisher = "Springer Japan",

number = "1",

}

TY - JOUR

T1 - Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society

AU - Kuwano, Hiroyuki

AU - Nishimura, Yasumasa

AU - Oyama, Tsuneo

AU - Kato, Hiroyuki

AU - Kitagawa, Yuko

AU - Kusano, Motoyasu

AU - Shimada, Hideo

AU - Takiuchi, Hiroya

AU - Toh, Yasushi

AU - Doki, Yuichiro

AU - Naomoto, Yoshio

AU - Matsubara, Hisahiro

AU - Miyazaki, Tatsuya

AU - Muto, Manabu

AU - Yanagisawa, Akio

N1 - Funding Information: Funds to support the development of these guidelines were provided by the Japan Esophageal Society and the Ministry of Health, Labour and Welfare Scientific Research (Study on the appropriate development and publication of guidelines for the diagnosis and treatment while maintaining full disclosure: Hirata’s study group). Prof. Kitagawa has received grants from Taiho Pharmaceutical CO., LTD., Chugai Pharmaceutical CO., LTD., Kyowa Hakko Kirin CO., LTD., Merck Serono CO., LTD., Ono Pharmaceutical CO., LTD., Novartis Pharma CO., LTD., Yakult Honsha CO., LTD., Bristol-Myers Squibb Daiichi Sankyo CO., LTD., Shionogi CO., LTD., Terumo Corporation, Torii Pharmaceutical Co., Ltd., AstraZeneca CO., LTD. Other authors have no conflict of interest to declare with profit making or nonprofit organizations or providers of medical products and medical supplies. The Ethics Committee and Administrative Board of the Japan Esophageal Society required members of the Committee to Develop Guidelines for the Treatment of Carcinoma of the Esophagus and the Guideline Evaluation Committee to self-report any potential conflict of interest.

PY - 2015/1/1

Y1 - 2015/1/1

KW - Clinical guidelines

KW - Esophagus

KW - Neoplasm

UR - http://www.scopus.com/inward/record.url?scp=84929336574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929336574&partnerID=8YFLogxK

U2 - 10.1007/s10388-014-0465-1

DO - 10.1007/s10388-014-0465-1

M3 - Article

AN - SCOPUS:84929336574

SN - 1612-9059

VL - 12

SP - 1

EP - 30

JO - Esophagus

JF - Esophagus

IS - 1

ER -